Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Infection sample collections and testing that are performed on human body samples like urine, saliva and blood for the detection of medical conditions or diseases at home is called infection home collection and testing. It is becoming a popular sample collection and testing process among the patient population owing to its benefits such as cost-effectiveness and confidential and quick response. Increasing awareness of home care testing among the population results in the potential growth of the market.
The market for infection home collection and testing market is expected to witness rapid growth during the forecast period. The major growth factors such as increased demand for portable and rapid testing devices, growing healthcare market in the emerging economies, and growing efforts by medical technology companies to provide patient comfort while ensuring the safety of healthcare professionals are likely to contribute to the growth of the market. Likewise, surge in the demand for at-home diagnostic testing for infectious diseases is further expected to improve market growth.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the infection home collection and testing market. In addition, complete analysis of changes on infection home collection and testing market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. A growing technological advancements in the field of at-home COVID-19 infection testing is likely to improve market growth in the coming years.
The study analyses global infection home collection and testing market based on disease type, sample type and geography.
Based on disease type, the market is segmented into hepatitis, human immunodeficiency virus, human papillomavirus, tuberculosis, influenza, and others. Human immunodeficiency virus is likely to witness rapid growth during the forecast period. An at-home HIV diagnostic test has been on the market for many years. It is the only US Food and Drug Administration (FDA)-approved at-home diagnostic test for an infectious disease. Alternatively, home influenza testing is currently being pursued, largely to improve infection control and antiviral prescribing. This ultimately propelling the market growth.
Based on sample type, the market is segmented into urine, blood, saliva, others. Blood segment is projected to witness rapid growth during the forecast period. Increasing chronic & lifestyle diseases and growing technological advancements in blood collection products and procedures are likely to contribute to the market growth.
Geographically, the study is comprised of the key countries of North America, Europe, Asia-Pacific and Rest of the World. North America held the largest market share of global infection home collection and testing market and is likely to dominate the market over the estimated time frame. High prevalence rate of diseases such as hepatitis, human immunodeficiency virus and human papillomavirus across the region is major factor that attributed to the growth of the market. Additionally, growing technological advancements in medical devices, well-established healthcare industry and surged demand for home sample collection tests for HIV infection are likely to impel market growth during the projection period.
The major key players of market includes Abbott Laboratories, ACON Laboratories Inc, Becton Dickinson & Company, BTNX Inc, Danaher Corporation, Medtronic plc, Quidel Corporation, Roche Holding AG, Siemens Healthineers and True Diagnostics Inc among others.
The study analyses global Infection Home Collection and Testing market based on disease type, sample type and geography. Infection home collection and testing market by disease type is segmented into hepatitis, human immunodeficiency virus, human papillomavirus, tuberculosis, influenza, and others. The human immunodeficiency virus segment is likely to dominate the market over the forecast period. By sample type, the market is segmented into urine, blood, saliva, and others. Geographically, the study is comprised of the key countries of North America, Europe, Asia-Pacific and Rest of the World.
Why to buy this report:
